Related Experiment Video
Updated: Aug 15, 2026
Delivery of Exogenous Artificially Synthesized miRNA Mimic to the Kidney Using Polyethylenimine Nanoparticles in Several Kidney Disease Mouse Models
Published on: May 10, 2022
Folate-Targeted Co-Delivery of Curcumin and siRela Nanoparticles Synergistically Treat Sepsis-Associated Acute Kidney
Xiangyi Xu1,2,3, Jingjin Tao1,2,3, Zhongjun Shen1,2,3
1Institute of Medical Technology, Peking University Health Science Center, Beijing 100191, China.
None:
The increasing burden of Acute Kidney Injury (AKI) significantly impacts human health. Approximately 70% of septic patients develop AKI, which markedly increases the risk of in-hospital mortality. However, current treatment for Sepsis-Associated Acute Kidney Injury (SA-AKI) is mainly supportive, and no specific therapy is available. siRNA therapy is an emerging approach that inhibits mRNA of specific targets to exert therapeutic effects. Based on the gene silencing principle of siRNA, we developed a targeted bifunctional coloaded nanoparticle, PDA@Cur-PEI-PEG-FA/siRela (PCPPFS), using folic acid (FA) as a targeting moiety. In this system, curcumin acts as a therapeutic agent and synergizes with siRela to exert anti-inflammatory and antioxidative stress effects, thereby reducing apoptosis and pyroptosis of renal tubular epithelial cells. This nanosystem demonstrated good targeting and therapeutic effects in both in vitro and in vivo experiments, providing a new approach for SA-AKI therapy.